Latest AI Stock Forecasts - All Predictions

Signal date 2026-10-15 Cut-offs from the 2026-10-15 run

Companies scored 2696 IC ≥ 0 · market cap ≥ $100M

Median forecast -0.28% Alpha · 90D

Long–short spread +5.12% Strong Buy minus Strong Sell, mean

Median IC 0.28 Spearman · 90D

Rating changes ▲ 549 ▼ 696 vs the previous run

Cross-section

Distribution of the day's forecasts

90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).

-3.4% 0 +4.0%

Signals · All

304 companies

Sorted by market cap ↓ · forecast rankings are part of the paid plans

#	Ticker	Sector	IC	Mkt cap	Rating	30D	90D	Δ
51	PRAXPraxis Precision Medicines, Inc.	Life Sciences	0.42	$6.7B	Unlock rating and forecasts
52	ALKSAlkermes plc.	Life Sciences	0.44	$6.6B	Unlock rating and forecasts
53	LNTHLantheus Holdings, Inc.	Life Sciences	0.11	$6.5B	Unlock rating and forecasts
54	IOVAIOVANCE BIOTHERAPEUTICS, INC.	Life Sciences	0.40	$6.4B	Unlock rating and forecasts
55	KNSAKiniksa Pharmaceuticals International, plc	Life Sciences	0.00	$6.2B	Unlock rating and forecasts
56	AMRXAmneal Pharmaceuticals, Inc.	Life Sciences	0.49	$6.0B	Unlock rating and forecasts
57	LGNDLIGAND PHARMACEUTICALS INC	Life Sciences	0.03	$5.9B	Neutral	-0.38%	-0.80%	▲ 1
58	IMVTImmunovant, Inc.	Life Sciences	0.27	$5.8B	Unlock rating and forecasts
59	CGONCG Oncology, Inc.	Life Sciences	0.23	$5.5B	Unlock rating and forecasts
60	MIRMMirum Pharmaceuticals, Inc.	Life Sciences	0.05	$5.2B	Unlock rating and forecasts
61	ERASErasca, Inc.	Life Sciences	0.43	$5.1B	Unlock rating and forecasts
62	KODKodiak Sciences Inc.	Life Sciences	0.00	$5.1B	Unlock rating and forecasts
63	ORKAOruka Therapeutics, Inc.	Life Sciences	0.49	$5.1B	Unlock rating and forecasts
64	TVTXTravere Therapeutics, Inc.	Life Sciences	0.31	$5.0B	Unlock rating and forecasts
65	PTCTPTC THERAPEUTICS, INC.	Life Sciences	0.13	$5.0B	Unlock rating and forecasts
66	COGTCogent Biosciences, Inc.	Life Sciences	0.21	$4.9B	Neutral	-0.09%	-0.14%	▲ 1
67	CRSPCRISPR Therapeutics AG	Life Sciences	0.30	$4.9B	Unlock rating and forecasts
68	SRRKScholar Rock Holding Corp	Life Sciences	0.21	$4.8B	Unlock rating and forecasts
69	MANEVeradermics, Inc	Life Sciences	0.20	$4.7B	Unlock rating and forecasts
70	DFTXDefinium Therapeutics, Inc.	Life Sciences	0.20	$4.6B	Unlock rating and forecasts
71	DNTHDianthus Therapeutics, Inc. /DE/	Life Sciences	0.39	$4.2B	Unlock rating and forecasts
72	ADPTAdaptive Biotechnologies Corp	Life Sciences	0.16	$4.1B	Unlock rating and forecasts
73	INDVIndivior Pharmaceuticals, Inc.	Life Sciences	0.51	$4.0B	Unlock rating and forecasts
74	EWTXEdgewise Therapeutics, Inc.	Life Sciences	0.24	$4.0B	Unlock rating and forecasts
75	ABCLAbCellera Biologics Inc.	Life Sciences	0.35	$3.8B	Unlock rating and forecasts
76	TNGXTango Therapeutics, Inc.	Life Sciences	0.36	$3.7B	Unlock rating and forecasts
77	RLAYRelay Therapeutics, Inc.	Life Sciences	0.43	$3.7B	Unlock rating and forecasts
78	OGNOrganon & Co.	Life Sciences	0.44	$3.6B	Unlock rating and forecasts
79	TLXTelix Pharmaceuticals Ltd	Life Sciences	0.05	$3.6B	Unlock rating and forecasts
80	LEGNLegend Biotech Corp	Life Sciences	0.02	$3.5B	Neutral	-0.28%	-0.55%	·
81	AMLXAmylyx Pharmaceuticals, Inc.	Life Sciences	0.31	$3.4B	Unlock rating and forecasts
82	ARQTArcutis Biotherapeutics, Inc.	Life Sciences	0.29	$3.3B	Unlock rating and forecasts
83	ACADACADIA PHARMACEUTICALS INC	Life Sciences	0.39	$3.3B	Unlock rating and forecasts
84	XENEXenon Pharmaceuticals Inc.	Life Sciences	0.44	$3.3B	Unlock rating and forecasts
85	IDYAIDEAYA Biosciences, Inc.	Life Sciences	0.30	$3.3B	Unlock rating and forecasts
86	TARSTarsus Pharmaceuticals, Inc.	Life Sciences	0.02	$3.2B	Unlock rating and forecasts
87	LQDALiquidia Corp	Life Sciences	0.14	$3.0B	Unlock rating and forecasts
88	VKTXViking Therapeutics, Inc.	Life Sciences	0.03	$3.0B	Unlock rating and forecasts
89	ELVNEnliven Therapeutics, Inc.	Life Sciences	0.43	$2.9B	Unlock rating and forecasts
90	RCUSArcus Biosciences, Inc.	Life Sciences	0.17	$2.9B	Unlock rating and forecasts
91	RADXRadiopharm Theranostics Ltd	Life Sciences	0.23	$2.6B	Unlock rating and forecasts
92	NEOGNEOGEN CORP	Life Sciences	0.36	$2.6B	Unlock rating and forecasts
93	PGENPRECIGEN, INC.	Life Sciences	0.31	$2.6B	Neutral	+0.11%	+0.24%	▼ 2
94	LIFEaTYR PHARMA INC	Life Sciences	0.46	$2.5B	Unlock rating and forecasts
95	NRIXNurix Therapeutics, Inc.	Life Sciences	0.26	$2.5B	Neutral	-0.11%	-0.18%	·
96	BEAMBeam Therapeutics Inc.	Life Sciences	0.20	$2.4B	Unlock rating and forecasts
97	HCMHUTCHMED (China) Ltd	Life Sciences	0.12	$2.4B	Neutral	+0.04%	+0.10%	·
98	MBXMBX Biosciences, Inc.	Life Sciences	0.07	$2.4B	Unlock rating and forecasts
99	ADMAADMA BIOLOGICS, INC.	Life Sciences	0.26	$2.3B	Unlock rating and forecasts
100	PBHPrestige Consumer Healthcare Inc.	Life Sciences	0.28	$2.3B	Unlock rating and forecasts

Breadth

By sector

Median 90D forecast per sector. Click to filter.

Life Sciences304 +1.2% Finance or Crypto Assets44 +0.6% Technology369 0.0% Finance389 -0.2% Trade & Services351 -0.4% Energy & Transportation288 -0.5% Manufacturing430 -0.6% Industrial Applications and Services285 -0.6% Real Estate & Construction225 -0.7% Crypto Assets11 -2.9%

Since the previous run

Rating changes

▲ 549▼ 696

Which companies were upgraded or downgraded is part of the paid plans.

Next step

Unlock the full ranking

Every company's rating, its 30- and 90-day forecasts, the forecast and IC-weighted rankings, the daily rating changes and CSV export.

See plans Create a free account

Methodology

Ratings are relative: the forecasts of the latest complete daily run (2026-10-15) are ranked and cut at the 15th, 35th, 65th and 85th percentiles, so Strong Sell is the bottom 15%, Sell the next 20%, Neutral the middle 30%, Buy the next 20% and Strong Buy the top 15%. Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. IC is the company's Spearman information coefficient between its past forecasts and the realised returns at the selected horizon; IC-weighted ranking multiplies each forecast by its IC (negative IC counts as zero). Δ is the rating move since the company's previous signal, in rating steps. Each company shows its latest signal, including one from a run still in progress; every signal is rated against the cut-offs above. Quantitative research output, not investment advice.

Daily Signals

Distribution of the day's forecasts

304 companies

By sector

Rating changes

Unlock the full ranking

AI Stock Finder Assistant

Cookie Settings

Essential Cookies

Analytics Cookies

Daily Signals

Distribution of the day's forecasts

304 companies

By sector

Rating changes

Unlock the full ranking